We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
(+3.3%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$12.1M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$11.5M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$7.47M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$65.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$17.5M |
| 3 |
Plains All American Pipeline
PAA
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$15.4M |
| 5 |
Targa Resources
TRGP
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Financials | 13.41% |
| 3 | Healthcare | 12.54% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
1801
Trueblue
TBI
$304M
| $306K | ﹤0.01% |
13,895
-1,527
| -10% | -$31.3K |
|
1802
Columbia Financial
CLBK
$1.22B
| $306K | ﹤0.01% |
17,478
| – | – |
|
1803
Adtran
ADTN
$664M
| $305K | ﹤0.01% |
18,277
+4,296
| +31% | +$72.4K |
|
|
NFBK
1804
DELISTED
Northfield Bancorp
NFBK
| $304K | ﹤0.01% |
19,119
-247
| -1% | -$3.47K |
|
|
PAND
1805
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $304K | ﹤0.01% |
+5,066
| New | +$183K |
|
1806
Alpha and Omega Semiconductor
AOSL
$945M
| $303K | ﹤0.01% |
9,268
| – | – |
|
1807
Genesco
GCO
$389M
| $302K | ﹤0.01% |
6,357
| – | – |
|
1808
V2X
VVX
$2.51B
| $302K | ﹤0.01% |
5,647
| – | – |
|
1809
Replimune Group
REPL
$1.45B
| $301K | ﹤0.01% |
9,865
| – | – |
|
1810
Acco Brands
ACCO
$403M
| $301K | ﹤0.01% |
35,657
+7,444
| +26% | +$64.1K |
|
1811
Ducommun
DCO
$3.03B
| $300K | ﹤0.01% |
4,992
| – | – |
|
|
EBSB
1812
DELISTED
Meridian Bancorp, Inc.
EBSB
| $298K | ﹤0.01% |
16,193
-7,099
| -30% | -$120K |
|
|
ARCH
1813
DELISTED
Arch Resources, Inc.
ARCH
| $298K | ﹤0.01% |
7,165
| – | – |
|
1814
Sutro Biopharma
STRO
$356M
| $298K | ﹤0.01% |
1,308
+50
| +4% | +$11.9K |
|
1815
Kelly Services Class A
KELYA
$546M
| $297K | ﹤0.01% |
13,358
-1,586
| -11% | -$33.7K |
|
1816
Designer Brands
DBI
$308M
| $297K | ﹤0.01% |
17,083
-9,721
| -36% | -$122K |
|
1817
Annexon
ANNX
$881M
| $297K | ﹤0.01% |
10,674
+3,840
| +56% | +$106K |
|
|
CCF
1818
DELISTED
Chase Corporation
CCF
| $296K | ﹤0.01% |
2,546
-987
| -28% | -$110K |
|
1819
Nurix Therapeutics
NRIX
$2.78B
| $296K | ﹤0.01% |
9,510
+4,421
| +87% | +$167K |
|
1820
Clearwater Paper
CLW
$353M
| $295K | ﹤0.01% |
7,836
| – | – |
|
|
ALTA
1821
DELISTED
Altabancorp
ALTA
| $295K | ﹤0.01% |
7,011
| – | – |
|
1822
SFL Corp
SFL
$1.62B
| $293K | ﹤0.01% |
36,594
+16,459
| +82% | +$122K |
|
1823
DMC Global
BOOM
$154M
| $292K | ﹤0.01% |
5,386
-1,710
| -24% | -$98.1K |
|
|
BRSP
1824
BrightSpire Capital
BRSP
$630M
| $292K | ﹤0.01% |
34,239
+8,170
| +31% | +$69.5K |
|
|
XENT
1825
DELISTED
Intersect ENT, Inc
XENT
| $292K | ﹤0.01% |
13,971
| – | – |
|
Similar funds
SPIA
BG
PCM
CS
HHII
EIM
P
MetLife Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.
- MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
- MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
- MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
- MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
- MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
- MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
- MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.
Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.